Previously, we described a prognostic model comprising five DNA methylation markers (i.e., GREM1, GATA5, LAD1, NEFH, and NEURL) in combination with clinicopathological characteristics (i.e., age at diagnosis, sex, Fuhrman grade, tumor size, and TNM stage) [12]. Here, LAD1 is linked to neoplasm.